IBDEI0EU ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7164,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,7165,0)
 ;;=280.9^^55^577^86
 ;;^UTILITY(U,$J,358.3,7165,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7165,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,7165,1,5,0)
 ;;=5^Iron Defic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,7165,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,7166,0)
 ;;=285.1^^55^577^84
 ;;^UTILITY(U,$J,358.3,7166,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7166,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,7166,1,5,0)
 ;;=5^Iron Defic Anemia d/t Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,7166,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,7167,0)
 ;;=280.0^^55^577^85
 ;;^UTILITY(U,$J,358.3,7167,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7167,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,7167,1,5,0)
 ;;=5^Iron Defic Anemia d/t Chronic Blood Loss
 ;;^UTILITY(U,$J,358.3,7167,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,7168,0)
 ;;=281.9^^55^577^107
 ;;^UTILITY(U,$J,358.3,7168,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7168,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,7168,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,7168,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,7169,0)
 ;;=281.0^^55^577^123
 ;;^UTILITY(U,$J,358.3,7169,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7169,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,7169,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,7169,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,7170,0)
 ;;=282.60^^55^577^111
 ;;^UTILITY(U,$J,358.3,7170,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7170,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,7170,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,7170,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,7171,0)
 ;;=282.62^^55^577^112
 ;;^UTILITY(U,$J,358.3,7171,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7171,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,7171,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,7171,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,7172,0)
 ;;=281.1^^55^577^124
 ;;^UTILITY(U,$J,358.3,7172,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7172,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,7172,1,5,0)
 ;;=5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,7172,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,7173,0)
 ;;=286.7^^55^577^54
 ;;^UTILITY(U,$J,358.3,7173,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7173,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,7173,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,7173,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,7174,0)
 ;;=289.9^^55^577^120
 ;;^UTILITY(U,$J,358.3,7174,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7174,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,7174,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,7174,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,7175,0)
 ;;=451.9^^55^577^121
 ;;^UTILITY(U,$J,358.3,7175,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7175,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,7175,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,7175,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,7176,0)
 ;;=446.6^^55^577^122
 ;;^UTILITY(U,$J,358.3,7176,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7176,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,7176,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(Ttp)
 ;;^UTILITY(U,$J,358.3,7176,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,7177,0)
 ;;=286.4^^55^577^125
 ;;^UTILITY(U,$J,358.3,7177,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7177,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,7177,1,5,0)
 ;;=5^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,7177,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,7178,0)
 ;;=204.00^^55^577^1
 ;;^UTILITY(U,$J,358.3,7178,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7178,1,4,0)
 ;;=4^204.00
